1 not yet recruiting, 1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Neurocutaneous melanosis: new trials by email Literature Review of Neurocutaneous melanosis trials Research Report on Neurocutaneous melanosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults Mirdametinib - LGCMN, Large and Giant Congenital Melanocytic Nevi | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 15 | 2027-01-04 | 2026-10-29 |
| Neurocutaneous Melanocytosis Registry Cutaneous Melanocytic Neoplasm, Large Cutaneous Melanocytic Nevi | Recruiting | Memorial Sloan Kettering Cancer Center | 100 | 2020-09-03 | 2026-10-05 |
Arachnoid Cysts (1) · Astrocytoma (1) · Ependymoma (1) · Melanoma (1)
Central Nervous System Cysts (1) · Central Nervous System Neoplasms (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cysts (1) · Glioma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Nervous System Malformations (1)
mirdametinib (1)
Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (2)
Marielle E Yohe, M.D. (1) · Yasmin Khakoo, MD (1)